Paroxysmal nocturnal haemoglobinuria - eculizumab or ravulizumab - initial, switching, returning or balance of supply authority application form (PB327)

Use this form to apply for initial, switching, returning or balance of supply PBS-subsidised treatment with eculizumab or ravulizumab for paroxysmal nocturnal haemoglobinuria.

Please note: You don’t need to complete this form if you use the Online PBS Authorities system.

Download and complete the paroxysmal nocturnal haemoglobinuria - eculizumab or ravulizumab - initial, switching, returning or balance of supply authority application form.

Page last updated: 1 December 2025.
QC 62063